Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
Go back to Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights| (NASDAQ: DNLI) | Delayed: 24.82 +0.05 (0.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.77 | 52 Week High | $ | |||
| Open | $25.14 | 52 Week Low | $ | |||
| Day High | $25.69 | P/E | N/A | |||
| Day Low | $24.72 | EPS | $ | |||
| Volume | 1,493,719 | |||||

